Hollencrest Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.41K | Hold |
14
| – | – | ﹤0.01% | 902 |
|
|
2026
Q1 | $4.1K | Hold |
14
| – | – | ﹤0.01% | 954 |
|
|
2025
Q4 | $4.91K | Hold |
14
| – | – | ﹤0.01% | 917 |
|
|
2025
Q3 | $4.52K | Hold |
14
| – | – | ﹤0.01% | 905 |
|
|
2025
Q2 | $5.45K | Sell |
14
-352
| -96% | -$142K | ﹤0.01% | 858 |
|
|
2025
Q1 | $159K | Sell |
366
-1,049
| -74% | -$421K | 0.01% | 307 |
|
|
2024
Q4 | $522K | Buy |
1,415
+4
| +0.3% | +$1.67K | 0.02% | 194 |
|
|
2024
Q3 | $734K | Sell |
1,411
-177
| -11% | -$94.6K | 0.03% | 173 |
|
|
2024
Q2 | $860K | Buy |
1,588
+3
| +0.2% | +$1.59K | 0.04% | 155 |
|
|
2024
Q1 | $822K | Buy |
1,585
+48
| +3% | +$23.9K | 0.04% | 156 |
|
|
2023
Q4 | $725K | Sell |
1,537
-42
| -3% | -$19.4K | 0.07% | 154 |
|
|
2023
Q3 | $688K | Buy |
1,579
+3
| +0.2% | +$1.36K | 0.08% | 137 |
|
|
2023
Q2 | $700K | Sell |
1,576
-11
| -0.7% | -$5.07K | 0.07% | 143 |
|
|
2023
Q1 | $730K | Buy |
1,587
+3
| +0.2% | +$1.43K | 0.08% | 134 |
|
|
2022
Q4 | $813K | Buy |
1,584
+528
| +50% | +$268K | 0.1% | 112 |
|
|
2022
Q3 | $480K | Sell |
1,056
-1,267
| -55% | -$606K | 0.06% | 157 |
|
|
2022
Q2 | $1.12M | Sell |
2,323
-198
| -8% | -$98K | 0.13% | 90 |
|
|
2022
Q1 | $1.24M | Buy |
2,521
+185
| +8% | +$84.6K | 0.11% | 99 |
|
|
2021
Q4 | $1.08M | Buy |
2,336
+2
| +0.1% | +$841 | 0.09% | 117 |
|
|
2021
Q3 | $870K | Buy |
2,334
+770
| +49% | +$293K | 0.08% | 132 |
|
|
2021
Q2 | $598K | Sell |
1,564
-780
| -33% | -$298K | 0.05% | 175 |
|
|
2021
Q1 | $841K | Buy |
2,344
+979
| +72% | +$315K | 0.08% | 132 |
|
|
2020
Q4 | $438K | Hold |
1,365
| – | – | 0.05% | 190 |
|
|
2020
Q3 | $367K | Buy |
1,365
+32
| +2% | +$8.61K | 0.04% | 202 |
|
|
2020
Q2 | $350K | Sell |
1,333
-4
| -0.3% | -$1.07K | 0.05% | 190 |
|
|
2020
Q1 | $303K | Sell |
1,337
-292
| -18% | -$79.6K | 0.04% | 194 |
|
|
2019
Q4 | $492K | Buy |
1,629
+135
| +9% | +$37.1K | 0.06% | 177 |
|
|
2019
Q3 | $359K | Buy |
1,494
+47
| +3% | +$12.9K | 0.04% | 193 |
|
|
2019
Q2 | $408K | Hold |
1,447
| – | – | 0.05% | 185 |
|
|
2019
Q1 | $416K | Buy |
1,447
+55
| +4% | +$15.9K | 0.06% | 178 |
|
|
2018
Q4 | $366K | Sell |
1,392
-1,447
| -51% | -$398K | 0.05% | 179 |
|
|
2018
Q3 | $797K | Buy |
2,839
+1,320
| +87% | +$343K | 0.05% | 184 |
|
|
2018
Q2 | $361K | Sell |
1,519
-56
| -4% | -$13K | 0.05% | 192 |
|
|
2018
Q1 | $346K | Buy |
1,575
+112
| +8% | +$26.3K | 0.05% | 197 |
|
|
2017
Q4 | $329K | Hold |
1,463
| – | – | 0.04% | 209 |
|
|
2017
Q3 | $278K | Buy |
1,463
+142
| +11% | +$27K | 0.04% | 229 |
|
|
2017
Q2 | $249K | Sell |
1,321
-142
| -10% | -$25.5K | 0.04% | 236 |
|
|
2017
Q1 | $242K | Buy |
+1,463
| New | +$233K | 0.04% | 286 |
|
Other funds holding ELV
Hollencrest Capital Management's ELV Position: Q2 2026 in Review
Hollencrest Capital Management held its Elevance Health (ELV) position steady in Q2 2026 at 14 shares worth $5.41K. The position accounts for ﹤0.01% of the portfolio, ranked #902.
Hollencrest Capital Management first reported a position in ELV in Q1 2017 and has held it in 38 quarters since. The position peaked at $1.24M in Q1 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Hollencrest Capital Management held 14 shares of Elevance Health worth $5.41K as of Q2 2026.
- Hollencrest Capital Management left its Elevance Health share count unchanged in Q2 2026.
- Elevance Health made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #902 holding.
- Hollencrest Capital Management first reported a position in Elevance Health in Q1 2017 and has held it in 38 quarters since.
- Hollencrest Capital Management's Elevance Health position peaked at $1.24M in Q1 2022.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.